BENGALURU: Biocon Foundation has unveiled a breathtaking public art spectacle, turning over 50 Metro pillars between Huskur ...

The healthcare sector, as of 2024, is one of India’s largest employers, employing a total of 7.5 million people. * The demand for Indian healthcare professionals is expected to double nationally and ...

The logo celebrates six decades of strong ties between the two nations. The design features elements symbolizing both countries: colours from the Indian and Singaporean national flags, the lotus ...

Biocon is set for major growth in the next 2-3 years, propelled by new generics and biosimilars. The Viatris acquisition ...

Equillium (EQ) and Biocon announced topline results from the Phase 2 study evaluating itolizumab in the treatment of moderate to severe ...

HYDERABAD -Indian biopharmaceutical firm Biocon is likely to list its key biosimilars business by March 2026 and aims for a double-digit share in its core U.S. market for its new launches ...

Biocon plans to list its biosimilars business by March 2026 and aims for a double-digit market share in the U.S. for five new biosimilars launching next fiscal year. The U.S. market, already ...

HYDERABAD (Reuters) -Indian biopharmaceutical firm Biocon is likely to list its key biosimilars business ... ThePrint holds no responsibility for its content. India needs fair, non-hyphenated and ...

Indian biopharmaceutical firm Biocon is likely to list its key biosimilars business by March 2026 and aims for double-digit share in its core US market for its new launches, a top executive told ...

after adjusting for the Branded Formulations India (BFI) revenue and income, which has since been divested. On Thursday, parent company Biocon Ltd said its board had approved the acquisition of a ...

HYDERABAD (Reuters) -Indian biopharmaceutical firm Biocon is likely to list its key biosimilars business by March 2026 and aims for double-digit share in its core U.S. market for its new launches, a ...